Exemestane Leads May Rises In UK
Pricewatch UK – May 2020
Executive Summary
Exemestane led the steepest price rises for generics seen in the UK in May. However, concession pricing for the breast cancer drug overestimated the actual prices in the market recorded by WaveData.